We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
-16.23%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$8.69B
AUM Growth
-$2.36B
(-21%)
Cap. Flow
-$272M
Cap. Flow
% of AUM
-3.14%
Top 10 Holdings %
Top 10 Hldgs %
17.49%
Holding
284
New
17
Increased
112
Reduced
145
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTRA
Coterra Energy
CTRA
|
+$62.4M |
| 2 |
Lyft
LYFT
|
+$61.2M |
| 3 |
Humana
HUM
|
+$61M |
| 4 |
SiTime
SITM
|
+$48.1M |
| 5 |
dLocal
DLO
|
+$43.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$108M |
| 2 |
LPL Financial
LPLA
|
+$55.1M |
| 3 |
Mattel
MAT
|
+$53.4M |
| 4 |
PDCE
PDC Energy, Inc.
PDCE
|
+$46.6M |
| 5 |
Coherent
COHR
|
+$46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.18% |
| 2 | Consumer Discretionary | 16.49% |
| 3 | Healthcare | 16.19% |
| 4 | Industrials | 14.84% |
| 5 | Financials | 14.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Tandem Diabetes Care
TNDM
$1.27B
| $3.83M | 0.04% |
64,689
-1,857
| -3% | -$152K |
|
252
SS&C Technologies
SSNC
$18.9B
| $3.76M | 0.04% |
64,763
-79,882
| -55% | -$5.14M |
|
|
SGEN
253
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.75M | 0.04% |
21,181
-7,733
| -27% | -$1.11M |
|
254
TPG
TPG
$6.76B
| $3.71M | 0.04% |
155,319
-4,465
| -3% | -$120K |
|
|
CIR
255
DELISTED
CIRCOR International, Inc
CIR
| $3.69M | 0.04% |
225,103
-69,591
| -24% | -$1.39M |
|
256
Stratasys
SSYS
$666M
| $3.56M | 0.04% |
189,818
+52,525
| +38% | +$1.03M |
|
257
Iovance Biotherapeutics
IOVA
$2.04B
| $3.5M | 0.04% |
317,389
-111,869
| -26% | -$1.47M |
|
258
Carvana
CVNA
$47.5B
| $3.14M | 0.04% |
695,465
+134,840
| +24% | +$1.42M |
|
|
XM
259
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $3.14M | 0.04% |
+250,849
| New | +$4.47M |
|
260
Guardant Health
GH
$19.1B
| $3.1M | 0.04% |
76,770
-305,554
| -80% | -$15.1M |
|
261
Vertiv
VRT
$85.7B
| $2.99M | 0.03% |
363,207
+39,066
| +12% | +$442K |
|
262
Karyopharm Therapeutics
KPTI
$155M
| $2.85M | 0.03% |
42,167
-43,119
| -51% | -$3.95M |
|
263
Toast
TOST
$18.9B
| $2.58M | 0.03% |
+199,557
| New | +$3.31M |
|
264
Five Below
FIVE
$11.6B
| $2.47M | 0.03% |
21,814
+20,117
| +1,185% | +$2.89M |
|
|
SWAV
265
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $2.34M | 0.03% |
12,228
-77,537
| -86% | -$13.7M |
|
266
Cytokinetics
CYTK
$10.6B
| $2.23M | 0.03% |
56,859
-352,691
| -86% | -$14.2M |
|
267
Arvinas
ARVN
$530M
| $2.19M | 0.03% |
51,991
+28,827
| +124% | +$1.45M |
|
268
Xponential Fitness
XPOF
$286M
| $1.96M | 0.02% |
155,829
+52,164
| +50% | +$939K |
|
269
BlackLine
BL
$1.9B
| $1.94M | 0.02% |
29,172
+8,882
| +44% | +$608K |
|
270
Adaptive Biotechnologies
ADPT
$3.61B
| $1.9M | 0.02% |
234,645
-362,228
| -61% | -$3.18M |
|
271
Ouster
OUST
$2.11B
| $1.02M | 0.01% |
62,914
-57,521
| -48% | -$1.61M |
|
|
NARI
272
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $897K | 0.01% |
13,186
-39,004
| -75% | -$2.8M |
|
|
AZEK
273
DELISTED
The AZEK Co
AZEK
| $633K | 0.01% |
37,810
-53,958
| -59% | -$1.11M |
|
|
APLS
274
DELISTED
Apellis Pharmaceuticals
APLS
| $274K | ﹤0.01% |
6,060
-9,489
| -61% | -$433K |
|
|
275
Advanced Micro Devices
AMD
$700B
| – | – |
-990,672
| Closed | -$108M |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Frontier Capital Management held 284 positions worth $8.69B, down 21% from $11B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Frontier Capital Management withdrew a net $272M in Q2 2022, closing 10 positions and reducing 145 holdings. Its most notable exit was Advanced Micro Devices, an estimated $108M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Frontier Capital Management opened a new position in Lyft worth $34.9M.
- Frontier Capital Management's largest Q2 2022 buy was Lyft: 2,625,629 shares worth $34.9M.
- Frontier Capital Management added most to Coterra Energy in Q2 2022, an estimated $62.4M increase.
- Frontier Capital Management's biggest Q2 2022 reduction was LPL Financial, cutting an estimated $55.1M.
- Frontier Capital Management fully exited Advanced Micro Devices in Q2 2022, selling an estimated $108M.
- Frontier Capital Management's ten largest holdings make up 17% of its $8.69B portfolio in Q2 2022.
- Frontier Capital Management opened 17 new positions and closed 10 in Q2 2022.
- Frontier Capital Management's portfolio value fell 21% quarter-over-quarter to $8.69B.
Based on Frontier Capital Management's 13F filing for Q2 2022, filed 20 Jul 2022.